Shree Akshar Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 2.38 Cr
as on 17-12-2024
- Company Age 29 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.00 M
as on 17-12-2024
- Satisfied Charges ₹ 2.80 M
as on 17-12-2024
- Revenue -6.43%
(FY 2020)
- Profit -36.07%
(FY 2020)
- Ebitda -25.03%
(FY 2020)
- Net Worth 10.77%
(FY 2020)
- Total Assets 13.03%
(FY 2020)
About Shree Akshar Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 Cr and a paid-up capital of Rs 2.38 Cr.
The company currently has active open charges totaling ₹4.00 M. The company has closed loans amounting to ₹2.80 M, as per Ministry of Corporate Affairs (MCA) records.
Sudhir Patel, Jitendrakumar Desai, and Miteshbhai Chaudhary serve as directors at the Company.
- CIN/LLPIN
U24230MH1995PTC093251
- Company No.
093251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Oct 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Shree Akshar Pharmaceuticals Private Limited offer?
Shree Akshar Pharmaceuticals Private Limited offers a wide range of products and services, including Ayurvedic Powder and Medicinal Herbs, Herbal Powder, Pharmaceutical Tablets, Weight Loss Supplement, Slimming Medicine, Ayurvedic Digestive Medicine, Ayurvedic Constipation Tablets Capsules, Ayurvedic,Herbal Products & Medicine, Ayurvedic Churna and Goli, Common Disease Medicines.
Who are the key members and board of directors at Shree Akshar Pharmaceuticals?
Board Members(3)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sudhir Patel | Director | 04-Oct-1995 | Current |
Jitendrakumar Desai | Director | 26-Mar-2002 | Current |
Miteshbhai Chaudhary | Additional Director | 07-Jul-2021 | Current |
Financial Performance of Shree Akshar Pharmaceuticals.
Shree Akshar Pharmaceuticals Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 6.43% decrease. The company also saw a substantial fall in profitability, with a 36.07% decrease in profit. The company's net worth Soared by an impressive increase of 10.77%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Shree Akshar Pharmaceuticals?
In 2020, Shree Akshar Pharmaceuticals had a promoter holding of 12.60% and a public holding of 87.40%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 28 Dec 2017 | ₹4.00 M | Open |
Dena Bank Creation Date: 09 Sep 1997 | ₹2.80 M | Satisfied |
How Many Employees Work at Shree Akshar Pharmaceuticals?
Shree Akshar Pharmaceuticals has a workforce of 31 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shree Akshar Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shree Akshar Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.